Inventiva (IVA) Interest Expenses (2019 - 2022)
Inventiva (IVA) posted quarterly Interest Expenses of -$33958.8 for Q2 2025, down 26.14% year-over-year from -$45975.3 in Q2 2024, and down 27.12% quarter-over-quarter from -$26714.9 in Q4 2024.
Analysis
Inventiva (IVA) Interest Expenses (2019 - 2022) Analysis & Trends
Inventiva's Interest Expenses history runs 7 years deep, the most recent figure standing at -$33958.8 for Q2 2025.
- In Q2 2025, Interest Expenses fell 26.14% year-over-year to -$33958.8; the TTM figure through Dec 2025 stood at $111439.1 (up 517.14% YoY), while the FY2025 annual figure was $252.5 million, up 165.75% from the prior year.
- Interest Expenses for Q2 2025 stood at -$33958.8, down from -$26714.9 in the prior quarter.
- The five-year high for Interest Expenses was $93805.6 in Q4 2021, with the low at -$2.7 million in Q1 2021.
- The 5-year median for Interest Expenses is -$26818.5 (2024), against an average of -$530827.1.
- Peak annual rise in Interest Expenses reached 337.09% in 2021, while the deepest fall reached 18794.71% in 2021.
- Inventiva's Interest Expenses stood at $93805.6 in 2021, then plunged by 41.27% to $55093.4 in 2022, then slumped by 189.84% to -$49493.2 in 2023, then jumped by 46.02% to -$26714.9 in 2024, then retreated by 27.12% to -$33958.8 in 2025.
- Business Quant data shows IVA's Interest Expenses at -$33958.8 in Q2 2025, -$26714.9 in Q4 2024, and -$26922.2 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Inventiva | 887.31 Mn | 887.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -180,583.78 |
| Sep 22, 2022 | 56,345.74 |
| Dec 31, 2021 | 93,805.62 |
| Jun 30, 2021 | -2.64 Mn |
| Mar 31, 2021 | -2.71 Mn |
| Dec 31, 2020 | 21,461.22 |
| Jun 30, 2020 | -30,840.88 |
| Mar 31, 2020 | -14,351.21 |
| Dec 31, 2019 | -46,489.28 |